Prevalence and antifungal drug sensitivity of non-albicans Candida in oral rinse samples of self-caring elderly

Gerodontology

Volumn 28, Issue 4, 2011, Pages 246-252

  Meurman, Jukka H ^a,b   Pärnänen, Pirjo ^b   Seneviratne, C Jaya ^c   Samaranayake, Lakshman P ^c   Saarinen, Antti M J ^b   Kari, Kirsti ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

elderly; non albicans Candida; oral cavity; yeasts

Indexed keywords

AGE; AGED; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA; CLASSIFICATION; DRUG EFFECT; FEMALE; HUMAN; INDEPENDENT LIVING; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NONPARAMETRIC TEST; RISK; RISK FACTOR; SALIVA; STATISTICAL MODEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; CANDIDA; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; INDEPENDENT LIVING; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; ODDS RATIO; RISK FACTORS; SALIVA; STATISTICS, NONPARAMETRIC;

EID: 81555223114     PISSN: 07340664     EISSN: 17412358     Source Type: Journal    
DOI: 10.1111/j.1741-2358.2010.00407.x     Document Type: Article

References (25)

1. Hoegl L, Thoma-Greber E, Röcken M, Korting H,. Persistent oral candiosis by NCAC strains including Candida glabrata in a human immunodeficiency virus-infected patient observed over a period of 6 years. Mycoses 1998; 41: 335-338. (Pubitemid 28553055)
2. Baran J Jr, Klauber E, Barczak J, Riederer K, Khatib R,. Trends in antifungal susceptibility among Candida sp. urinary isolates from 1994 and 1998. J Clin Microbiol 2000; 38: 870-871. (Pubitemid 30082698)
3. Cowen LE, Sanglard D, Calabrese D, Sirjusingh C, Anderson JB, Kohn LM,. Evolution of drug resistance in experimental populations of Candida albicans. J Bacteriol 2000; 182: 1515-1522. (Pubitemid 30121114)
4. Da Costa KR, Ferreira JC, Komesu MC, Candido RC,. Candida albicans and Candida tropicalis in oral candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity. Mycopathologia 2009; 167: 173-179.
5. Lockhart SR, Joly S, Vargas K, Swails-Wenger J, Soll DR,. Natural defenses against Candida colonization breakdown in the oral cavities of the elderly. J Dent Res 1999; 78: 857-868. (Pubitemid 32489305)
6. Redding SW, Kirkpatrick WR, Saville S, et al. Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation. J Clin Microbiol 2003; 41: 619-622. (Pubitemid 36184171)
7. Gasparoto TH, Dionísio TJ, de Oliveira CE, et al. Isolation of Candida dubliniensis from denture wearers. J Med Microbiol 2009; 58: 959-962.
8. Coco BJ, Bagg J, Cross LJ, Jose A, Cross J, Ramage G,. Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis. Oral Microbiol Immunol 2008; 23: 377-383.
9. Pärnänen P, Kari K, Virtanen I, Sorsa T, Meurman JH,. Human laminin-332 degradation by Candida proteinases. J Oral Pathol Med 2008; 37: 329-335. (Pubitemid 351814327)
10. Pärnänen P, Meurman JH, Virtanen I,. Laminin-511 and fibronectin degradation with Candida yeasts. J Oral Pathol Med 2009; 38: 768-72.
11. Leroy O, Gangneux JP, Montravers P, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009; 37: 1612-1618.
12. Meurman JH, Pärnänen P, Kari K, Samaranayake L,. Effect of amine fluoride-stannous fluoride preparations on oral yeasts in the elderly: a randomised placebo-controlled trial. Gerodontology 2009; 26: 202-9.
13. Sintonen H,. The 15D instrument of health-related quality of life: properties and applications. Ann Med 2001; 33: 328-336. (Pubitemid 32675373)
14. Tsang CS, Samaranayake LP,. Oral yeasts and coliforms in HIV-infected individuals in Hong Kong. Mycoses 2000; 43: 303-308.
15. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. 2nd edn, Approved Standard M27-A2, Wayne, PA, USA: NCCLS, 2002.
16. Meurman JH, Rantonen P,. Salivary flow rate, buffering capacity, and yeast counts in 187 consecutive adult patients from Kuopio, Finland. Scand J Dent Res 1994; 102: 229-234.
17. Davies AN, Brailsford SR, Beighton D, Shorthose K, Stevens VC,. Oral candidosis in community-based patients with advanced cancer. J Pain Symptom Manage 2008; 35: 508-514.
18. Lewis RE,. Overview of the changing epidemiology of candidemia. Curr Med Res Opin 2009; 25: 1732-1740.
19. Lass-Flörl C, Mayr A, Perkhofer S, et al. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother 2008; 52: 3637-3641.
20. Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2009; 47: 117-123.
21. Pemán J, Cantõn E, Espinel-Ingroff A,. Antifungal drug resistance mechanisms. Expert Rev Anti Infect Ther 2009; 7: 453-460.
22. Akpan A, Morgan R,. Oral candidiasis. Postgrad Med J 2002; 78: 455-459. (Pubitemid 34948150)
23. Wang J, Ohshima T, Yasunari U, et al. The carriage of Candida species on the dorsal surface of the tongue: the correlation with the dental, periodontal and prosthetic status in elderly subjects. Gerodontology 2006; 23: 157-163.
24. Shen S, Samaranayake LP, Yip HK, Dyson JE,. Bacterial and yeast flora of root surface caries in elderly, ethnic Chinese. Oral Dis 2002; 8: 207-217. (Pubitemid 34815226)
25. Meurman JH, Siikala E, Richardson M, Rautemaa R,. Non-Candida albicans Candida yeasts in the oral cavity. In:, Méndez-Vilas A, ed. Communicating Current Research and Educational Topics and Trends in Applied Microbiology. Formatex Microbiology. Series No. 1 vol 2, Badajoz 2007, 719-731.